A world-first genetic test to prevent hearing loss in newborn babies has been conditionally recommended by NICE for use within the NHS. The pioneering system was developed in collaboration with Prof Newman and his team at Manchester BRC. Read more: manchesterbrc.nihr.ac.uk/news-and-event…

Patient and public involvement in #hearing research: opportunities, impact & reflections with case studies from #Manchester Centre for #Audiology and #Deafness #OpenAccess by Piers Dawes, Kevin J Munro & colleagues with @ManCAD_UoM & NIHR Manchester Biomedical Research Centre tandfonline.com/doi/full/10.10…

John McDermott Videha Sharma paul wilson building on NWGMSA The PALOH Trial #PGx with many colleagues across The University of Manchester MFT Research and Innovation Health Innovation Manchester The DEVOTE Programme

Patients with the m.1555A>G genetic variant are at increased risk of deafness when treated with antibiotics called aminoglycosides. Join our webinar to learn about the pharmacogenomic test for this variant: 📅 13 April 12-1pm 📅 10 May 1-2pm Visit bit.ly/3KaZ5Kn

World's 1st rapid test to identify a particular gene in babies +prevent antibiotic induced hearing loss - now recommend by NICE for use in NHS CE certified with potential US #FDA approval in the near future. #gdr genedrive plc The PALOH Trial MFT NHS #neonatal #AIHL

Preventing Hearing loss Through Genetic Screening: Exploring Genedrive's Game Changing Technology. genedrive plc #geneticscreening #hearinghealth #hearingloss #hearingcare youtu.be/ke3vSgB0tyU

As a society, we tend to focus a lot on risk and try to control it through regulation - but how well does that work in #genomic medicine? Kate Lyle talks to us about this in the 7th episode of the CPM podcast: podcasts.ox.ac.uk/series-2-episo…

Kate uses the brilliant The PALOH Trial to illustrate the issues, and you can read more about this in her fascinating article in J. of Medical Ethics: jme.bmj.com/content/49/5/3…

Great talk about rapid point of care testing to detect a genetic variant associated with aminoglycoside related ototoxicity. Potential for a huge impact in management of neonates with sepsis The PALOH Trial #rcpch2023

We're pleased to announce our shortlisted nominees for this year's BAPM Gopi Menon Awards. The winners will be announced on Tuesday 12 September at the BAPM Annual Conference. You can find the full shortlist here> bapm.org/pages/bapm-gop…

BSAC #grammegative2023 Waiting to present on The PALOH Trial and use of point of care testing to avoid hearing loss in neonates

The afternoon session at #ESPT23 is underway with Bill Newman speaking about the use of point of care systems in pharmacogenetics - discussing our experience of the The PALOH Trial with genedrive plc.

🎆Congratulations to Bill Newman John McDermott and the team at The University of Manchester MFT NHS on their nomination for STEM Research Project of the Year! Winners will be announced on 28th November, we wish you all the best of luck! the-awards.co.uk/2024/en/page/s… #GDR

🗞️ A pioneering genetic test developed by MFT NHS researchers, that could prevent critically ill newborn babies going deaf if treated with a commonly used antibiotic, is being trialled across 14 NHS specialist newborn units, in the new PALOH-UK study. 👇 research.cmft.nhs.uk/news-events/ge…

With £1.4m funding from National Institute for Health and Care Research and the Office for Life Sciences, PALOH-UK will demonstrate at a larger scale, how the test can be used in a timely way to ensure babies get a safe, effective antibiotic without affecting normal clinical practice. 👇 research.cmft.nhs.uk/news-events/ge…

Very proud to announce that tonight The PALOH Trial won the Times Higher Education STEM award for The University of Manchester #THEAwards

Congratulations to the PALOH team! Winner of Research Project of the Year: STEM at the Times Higher Education awards 2024 🏆 👏 Bill Newman, John McDermott and all involved The University of Manchester and MFT NHS. National Institute for Health and Care Research NIHR Manchester Biomedical Research Centre MFT Research and Innovation

Another incredible achievement for the PALOH team! Winner of Research Project of the Year: STEM at last night’s Times Higher Education awards 2024 🏆 Huge congratulations to all 👏

Congratulations to the PALOH study team who won Research Project of the Year: STEM at the Times Higher Education Awards 2024🏆👏. The team developed the world’s first bedside genetic test that can prevent critically ill newborn babies from going deaf if treated with a common antibiotic.

Huge congratulations to Bill Newman, John McDermott and the PALOH team at MFT NHS who won Research Project of the Year: STEM at Times Higher Education Awards last night!